Minyan Chen
Impact in
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
-
- Cancer-related molecular mechanisms research
Papers in
-
- Breast Cancer Treatment Studies 7
- Oncology 9
- Cancer-related Molecular Pathways 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Fangmeng Fu (13 shared papers)Chuan Wang (12 shared papers)Meng Huang (6 shared papers)Yuxiang Lin (17 shared papers)Yongfang Yuan (2 shared papers)Gang Yang (3 shared papers)Lili Chen (14 shared papers)Xiaobin Chen (9 shared papers)
- Journals
- International Journal of Cancer (2 papers)International Journal of Nanomedicine (2 papers)BMC Cancer (2 papers)The Breast (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Minyan Chen
35 papers receiving 483 citations
Peers
Comparison fields: 5 of 85
- Pharmaceutical Science 41
- Cancer Research 64
- Molecular Biology 227
- Reproductive Medicine 22
- Oncology 64
Countries citing papers authored by Minyan Chen
This map shows the geographic impact of Minyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minyan Chen more than expected).
Fields of papers citing papers by Minyan Chen
This network shows the impact of papers produced by Minyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minyan Chen. The network helps show where Minyan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Minyan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 106 | |
| 2 | 2013 | 48 | |
| 3 | 2022 | 47 | |
| 4 | 2019 | 45 | |
| 5 | 2022 | 41 | |
| 6 | 2014 | 21 | |
| 7 | 2020 | 21 | |
| 8 | 2020 | 20 | |
| 9 | 2008 | 15 | |
| 10 | 2014 | 14 | |
| 11 | 2023 | 12 | |
| 12 | 2024 | 11 | |
| 13 | 2023 | 9 | |
| 14 | 2015 | 9 | |
| 15 | 2024 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2016 | 7 | |
| 18 | 2016 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2022 | 4 |
About Minyan Chen
Minyan Chen is a scholar working on Cancer Research, Oncology, Genetics, Molecular Biology and Health, Toxicology and Mutagenesis, having authored 39 papers that have together received 490 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer-related Molecular Pathways (3 papers), BRCA gene mutations in cancer (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), RNA modifications and cancer (2 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Pharmaceutical Science (41 citations), Cancer Research (64 citations), Molecular Biology (227 citations), Reproductive Medicine (22 citations) and Oncology (64 citations). Minyan Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Fangmeng Fu, Chuan Wang, Meng Huang, Yuxiang Lin, Yongfang Yuan, Gang Yang, Lili Chen, Xiaobin Chen, Yaqin Zhang and Di Wang. Their work appears in journals such as International Journal of Cancer, International Journal of Nanomedicine, BMC Cancer, The Breast and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.